Platelets have a primary role in prevention of bleeding, and are vital
for the treatment of various forms of trauma and blood diseases.
However, they can only be obtained through blood donations at present.
Researchers reporting online February 13 in the Cell Press journal
Cell Stem Cell
recently found a way to create platelets without the need for donated
blood, an advance that could possibly erase supply shortages and ensure
platelet treatments for all who need them.
The supply of donated platelets, which have a short shelf life and must
be kept at room temperature, is often insufficient to meet clinical
needs. In addition, while transfused platelets do not typically need to
be immune-matched to patients, repeated transfusion of unmatched
platelets leads to an immune reaction that eventually renders patients
unresponsive to platelet transfusion therapy.
To address these limitations, investigators from Japan developed a
strategy to derive functional platelets from human induced pluripotent
stem cells. Induced pluripotent stem cells can be generated from various
types of cells in the body, and they can in turn be coaxed to develop
into nearly any other cell type. In the current study, the approach
involved genetically manipulating such stem cells to become stable
immortalized lines of platelet-producing cells called megakaryocyte
progenitors.
The megakaryocyte progenitors could produce large quantities of
platelets with clotting capabilities that were similar to those of
donated platelets. Unlike freshly donated platelets, though, the
immortalized megakaryocyte progenitors could be expanded and frozen for
long-term storage.
"Here we established a method to achieve the long-term self-replication
of megakaryocyte progenitors as an immortalized cell line, which could
eventually contribute to large-scale cultivation and production of
platelets," says senior author Dr. Koji Eto of Kyoto University and the
University of Tokyo.
Source:
University of Tokyo.
No comments:
Post a Comment